Major Research Funders, Institutions Pledge Transparency In Clinical Trials 18/05/2017 William New More transparency on clinical trials is expected after major research funders, research institutions, and international health groups agreed that the research they fund or support will publicly release results of clinical trials. Continue reading -> IFPMA Priorities At WHA: Election, Antibiotics, Cancer, Pandemics 17/05/2017 Catherine Saez The new head of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has hit the ground running in Geneva, and is weighing in on a variety of policy issues, this week providing a list of priorities for the research-based pharma industry at the upcoming annual World Health Assembly. Continue reading -> World Health Assembly Topic: Pandemic Flu Financing, Virus Sharing, Extension 17/05/2017 Catherine Saez There are many who see the World Health Organization mechanism to prepare and face the next influenza pandemic and insure availability of treatments as a success. However, some questions remain. Continue reading -> WHO, Stakeholders Take ‘First Step’ On Fair Pricing For Medicines 12/05/2017 Catherine Saez The World Health Organization has concluded a major one-day forum on fair pricing of medicines, bringing a wide range of stakeholders together in Amsterdam and coming up with several possible actions for the way ahead. Key points of discussion included a definition of fair pricing, moving away from value-based pricing, delinkage of price from research and development costs, and greater transparency, according to participants. Continue reading -> US, EU Diverge On Medical Diagnostic Patents 10/05/2017 Kim Treanor A recent article in the journal Nature Biotechnology finds that since a key United States Supreme Court decision, the European Union and United States have diverged in their patent filings for medical diagnostics. Continue reading -> Posts navigation Newer posts
IFPMA Priorities At WHA: Election, Antibiotics, Cancer, Pandemics 17/05/2017 Catherine Saez The new head of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has hit the ground running in Geneva, and is weighing in on a variety of policy issues, this week providing a list of priorities for the research-based pharma industry at the upcoming annual World Health Assembly. Continue reading -> World Health Assembly Topic: Pandemic Flu Financing, Virus Sharing, Extension 17/05/2017 Catherine Saez There are many who see the World Health Organization mechanism to prepare and face the next influenza pandemic and insure availability of treatments as a success. However, some questions remain. Continue reading -> WHO, Stakeholders Take ‘First Step’ On Fair Pricing For Medicines 12/05/2017 Catherine Saez The World Health Organization has concluded a major one-day forum on fair pricing of medicines, bringing a wide range of stakeholders together in Amsterdam and coming up with several possible actions for the way ahead. Key points of discussion included a definition of fair pricing, moving away from value-based pricing, delinkage of price from research and development costs, and greater transparency, according to participants. Continue reading -> US, EU Diverge On Medical Diagnostic Patents 10/05/2017 Kim Treanor A recent article in the journal Nature Biotechnology finds that since a key United States Supreme Court decision, the European Union and United States have diverged in their patent filings for medical diagnostics. Continue reading -> Posts navigation Newer posts
World Health Assembly Topic: Pandemic Flu Financing, Virus Sharing, Extension 17/05/2017 Catherine Saez There are many who see the World Health Organization mechanism to prepare and face the next influenza pandemic and insure availability of treatments as a success. However, some questions remain. Continue reading -> WHO, Stakeholders Take ‘First Step’ On Fair Pricing For Medicines 12/05/2017 Catherine Saez The World Health Organization has concluded a major one-day forum on fair pricing of medicines, bringing a wide range of stakeholders together in Amsterdam and coming up with several possible actions for the way ahead. Key points of discussion included a definition of fair pricing, moving away from value-based pricing, delinkage of price from research and development costs, and greater transparency, according to participants. Continue reading -> US, EU Diverge On Medical Diagnostic Patents 10/05/2017 Kim Treanor A recent article in the journal Nature Biotechnology finds that since a key United States Supreme Court decision, the European Union and United States have diverged in their patent filings for medical diagnostics. Continue reading -> Posts navigation Newer posts
WHO, Stakeholders Take ‘First Step’ On Fair Pricing For Medicines 12/05/2017 Catherine Saez The World Health Organization has concluded a major one-day forum on fair pricing of medicines, bringing a wide range of stakeholders together in Amsterdam and coming up with several possible actions for the way ahead. Key points of discussion included a definition of fair pricing, moving away from value-based pricing, delinkage of price from research and development costs, and greater transparency, according to participants. Continue reading -> US, EU Diverge On Medical Diagnostic Patents 10/05/2017 Kim Treanor A recent article in the journal Nature Biotechnology finds that since a key United States Supreme Court decision, the European Union and United States have diverged in their patent filings for medical diagnostics. Continue reading -> Posts navigation Newer posts
US, EU Diverge On Medical Diagnostic Patents 10/05/2017 Kim Treanor A recent article in the journal Nature Biotechnology finds that since a key United States Supreme Court decision, the European Union and United States have diverged in their patent filings for medical diagnostics. Continue reading -> Posts navigation Newer posts